|
|
Volumn 30, Issue 4 SUPPL. 15, 2003, Pages 1-4
|
|
Perspectives on oxaliplatin in the treatment of gastrointestinal cancers: Introduction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BORTEZOMIB;
CALCIUM;
CARBAMAZEPINE;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
DIHYDROPYRIMIDINE DEHYDROGENASE;
FLOXURIDINE;
FLUOROURACIL;
FOLINIC ACID;
GABAPENTIN;
GEFITINIB;
GEMCITABINE;
GLUTATHIONE;
IRINOTECAN;
MAGNESIUM;
OXALIPLATIN;
THYMIDINE PHOSPHORYLASE;
THYMIDYLATE SYNTHASE;
ANTINEOPLASTIC ACTIVITY;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CANCER RESEARCH;
CANCER SURVIVAL;
CELL DEATH;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
CONFERENCE PAPER;
DOSE KIDNEY FUNCTION RELATION;
DRUG ACTIVITY;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG RESEARCH;
DRUG RESPONSE;
DYSESTHESIA;
ESOPHAGUS CANCER;
HUMAN;
MAXIMUM TOLERATED DOSE;
MEDICAL LITERATURE;
NEUTROPENIA;
NONHUMAN;
ONCOLOGY;
PARESTHESIA;
PHARMACOGENETICS;
PRIORITY JOURNAL;
RECTUM CANCER;
SENSORY NEUROPATHY;
|
|
EID: 0141959167
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: 10.1016/s0093-7754(03)00398-1 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
